Repeated immune activation with low-dose lipopolysaccharide attenuates the severity of Huntington's disease in R6/2 transgenic mice

Huntington's disease (HD) is a neurodegenerative disorder caused by a mutation in the huntingtin gene. Previously, therapeutic approaches using anti-inflammatory agents were reportedly not effective for preventing HD progression. Since whether immune responses contribute to the onset of HD is n...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sung Won, Park, Hyun Jung, Im, Wooseok, Kim, Manho, Hong, Seokmann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138304/
https://www.ncbi.nlm.nih.gov/pubmed/30460101
http://dx.doi.org/10.1080/19768354.2018.1473291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138304/
https://www.ncbi.nlm.nih.gov/pubmed/30460101
http://dx.doi.org/10.1080/19768354.2018.1473291

Ejemplares similares